TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.

Yao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.